Concert Pharma (CNCE) Misses Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
Concert Pharmaceuticals Reports First Quarter 2022 Financial Results
May 5, 2022 7:00 AM EDTPhase 3 Data Readout in Alopecia Areata Expected Second Quarter of 2022
Alopecia Areata Represents Significant Market Opportunity with Important Medical Need
Conference Call Scheduled Today at 8:30 a.m. ET
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ:... More



